Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.

Sato T, Morita S, Bando H, Sato S, Ikeda T, Emi K.

Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):51-5. doi: 10.4103/0974-9233.106387.

2.

Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Smith JM, Steel DH.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD008214. doi: 10.1002/14651858.CD008214.pub3. Review.

PMID:
26250103
3.

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.

di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3.

PMID:
20135139
4.

Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.

Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R.

Ophthalmology. 2009 Oct;116(10):1943-8. doi: 10.1016/j.ophtha.2009.07.001.

PMID:
19699531
5.

Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.

Yeung L, Liu L, Wu WC, Kuo YH, Chao AN, Chen KJ, Yang KJ, Chen TL, Lai CC.

Acta Ophthalmol. 2010 Sep;88(6):635-40. doi: 10.1111/j.1755-3768.2008.01498.x.

6.

Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.

Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM.

Eur J Ophthalmol. 2009 Sep-Oct;19(5):848-52.

PMID:
19787608
7.

The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.

Ahn J, Woo SJ, Chung H, Park KH.

Ophthalmology. 2011 Nov;118(11):2218-26. doi: 10.1016/j.ophtha.2011.03.036.

PMID:
21724263
8.

Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.

Gupta A, Bansal R, Gupta V, Dogra MR.

Int Ophthalmol. 2012 Apr;32(2):135-44. doi: 10.1007/s10792-012-9541-5.

PMID:
22450558
9.

Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.

Park DH, Shin JP, Kim SY.

Graefes Arch Clin Exp Ophthalmol. 2010 May;248(5):641-50. doi: 10.1007/s00417-009-1247-7.

PMID:
20012643
10.

Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.

Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, Tano Y.

Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005.

PMID:
19269033
11.

The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.

Berk Ergun S, Toklu Y, Cakmak HB, Raza S, Simsek S.

Semin Ophthalmol. 2015 May;30(3):177-80. doi: 10.3109/08820538.2013.835847.

PMID:
24409948
12.

The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.

Göncü T, Özdek S, Ünlü M.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):88-93. doi: 10.5301/ejo.5000327.

PMID:
23787453
13.

Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.

Yang CM, Yeh PT, Yang CH, Chen MS.

Am J Ophthalmol. 2008 Aug;146(2):211-217. doi: 10.1016/j.ajo.2008.04.028.

PMID:
18547539
14.

Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.

Yeh PT, Yang CH, Yang CM.

Acta Ophthalmol. 2011 Nov;89(7):634-40. doi: 10.1111/j.1755-3768.2009.01821.x.

15.

Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.

Liu L, Wu WC, Yeung L, Wang NK, Kuo YH, Chao AN, Chen KJ, Chen TL, Lai CC, Hwang YS, Chen YP.

Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):72-7. doi: 10.3928/15428877-20091230-13.

PMID:
20128573
16.

Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.

Ushida H, Kachi S, Asami T, Ishikawa K, Kondo M, Terasaki H.

Ophthalmic Res. 2013;49(1):30-6. doi: 10.1159/000324135.

PMID:
23038607
17.

Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.

Cheema RA, Mushtaq J, Al-Khars W, Al-Askar E, Cheema MA.

Retina. 2010 Nov-Dec;30(10):1646-50. doi: 10.1097/IAE.0b013e3181d6def0.

PMID:
20634777
18.

Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials.

Zhang ZH, Liu HY, Hernandez-Da Mota SE, Romano MR, Falavarjani KG, Ahmadieh H, Xu X, Liu K.

Am J Ophthalmol. 2013 Jul;156(1):106-115.e2. doi: 10.1016/j.ajo.2013.02.008.

PMID:
23791371
19.

Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.

Patwardhan SD, Azad R, Shah BM, Sharma Y.

Retina. 2011 May;31(5):866-70. doi: 10.1097/IAE.0b013e3181f2a27f.

PMID:
21301382
20.

Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.

Farahvash MS, Majidi AR, Roohipoor R, Ghassemi F.

Retina. 2011 Jul-Aug;31(7):1254-60. doi: 10.1097/IAE.0b013e31820a68e5.

PMID:
21499192
Items per page

Supplemental Content

Support Center